Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
The DTacP-sIPV-Hib combination vaccine can replace the single-component acellular pertussis, diphtheria, tetanus, polio, and Haemophilus influenzae type B vaccines. In this study, we evaluated the safety and immunogenicity of a newly developed DTacP-sIPV-Hib combination vaccine in animal models. We...
| 出版年: | Human Vaccines & Immunotherapeutics |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis Group
2022-12-01
|
| 主題: | |
| オンライン・アクセス: | http://dx.doi.org/10.1080/21645515.2022.2160158 |
